Profil
Christopher Thorn worked as the Chief Financial Officer at Humanigen, Inc. in 2015 and as a Controller at Vyera Pharmaceuticals LLC.
He received an undergraduate degree and an MBA from St. John's University.
Anciens postes connus de Christopher Thorn
| Sociétés | Poste | Fin |
|---|---|---|
| HUMANIGEN, INC. | Directeur Financier/CFO | 21/12/2015 |
Vyera Pharmaceuticals LLC
 Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | - |
Formation de Christopher Thorn
| St. John's University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Vyera Pharmaceuticals LLC
Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Health Technology |